$18.8 M

VBIO Mkt cap, 22-Sept-2021
Vitality Biopharma Net income (Q1, 2022)-612.2 K
Vitality Biopharma EBIT (Q1, 2022)-612.2 K
Vitality Biopharma Cash, 30-Jun-2021321.4 K
Get notified regarding key financial metrics and revenue changes at Vitality BiopharmaLearn more
Banner background

Vitality Biopharma Income Statement

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

102.4k258.3k

Revenue growth, %

(37%)152%(100%)

Cost of goods sold

77.9k454.8k

Gross profit

24.5k(196.5k)

Gross profit Margin, %

24%(76%)

R&D expense

1.9m1.8m1.0m408.9k

General and administrative expense

2.5m3.7m2.7m1.9m

Operating expense total

4.4m13.5m3.7m2.3m

EBIT

(4.4m)(13.2m)(3.7m)(2.3m)

EBIT margin, %

(4293%)(5123%)

Interest expense

6.8k

Interest income

1.2k

Pre tax profit

(4.3m)(13.1m)(4.4m)(880.9k)

Net Income

(4.3m)(13.1m)(4.4m)(880.9k)

EPS

(0.2)(0.6)(0.1)0.0

Vitality Biopharma Balance Sheet

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Cash

656.3k6.0m2.4m884.1k

Accounts Receivable

13.8k19.4k

Prepaid Expenses

3.1k50.5k15.7k3.2k

Current Assets

675.8k6.1m2.4m896.8k

Total Assets

675.8k6.1m2.6m896.8k

Accounts Payable

200.5k721.9k862.5k33.4k

Short-term debt

125.7k

Current Liabilities

353.5k1.3m33.4k

Total Debt

125.7k

Total Liabilities

353.5k1.1m1.3m33.4k

Common Stock

24.1k52.1k50.6k50.6k

Additional Paid-in Capital

22.3m47.2m47.8m48.2m

Retained Earnings

(22.0m)(42.2m)(46.5m)(47.4m)

Total Equity

322.3k5.0m1.3m863.4k

Debt to Equity Ratio

0.1 x

Debt to Assets Ratio

0 x

Financial Leverage

2.1 x1.2 x2 x1 x

Vitality Biopharma Cash Flow

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

(4.3m)(13.1m)(4.4m)(880.9k)

Depreciation and Amortization

12.3k

Accounts Receivable

5.4k4.6k

Accounts Payable

(173.2k)291.1k216.4k(216.7k)

Cash From Operating Activities

(2.9m)(3.7m)(3.6m)(1.6m)

Cash From Investing Activities

141.5k

Cash From Financing Activities

2.4m8.9m97.0k

Net Change in Cash

(496.5k)5.3m(3.6m)(1.5m)

Income Taxes Paid

800.0

Quarterly

USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Net Income

(1.1m)(2.4m)(3.6m)(1.6m)(2.8m)(3.6m)(740.2k)(1.2m)(520.2k)(612.2k)

Accounts Receivable

7.2k(6.2k)(22.0k)

Accounts Payable

147.3k122.0k(37.9k)31.8k468.2k287.3k(106.0k)(160.3k)(178.0k)

Cash From Operating Activities

(483.3k)(1.1m)(2.4m)(1.3m)(2.0m)(2.9m)(719.3k)(1.1m)(1.0m)(562.7k)

Cash From Investing Activities

141.5k

Cash From Financing Activities

750.0k9.1m97.0k97.0k97.0k

Net Change in Cash

(483.3k)(319.6k)6.8m(1.3m)(2.0m)(2.9m)(622.3k)(1.0m)(950.8k)(562.7k)

Interest Paid

5.9k

Vitality Biopharma Ratios

USDFY, 2018

Revenue/Employee

14.6k

Financial Leverage

2.1 x

Vitality Biopharma Operating Metrics

FY, 2018FY, 2019FY, 2020FY, 2021

Patent Applications

1112

Patents (US)

11